SEARCH

SEARCH BY CITATION

References

  • Abbate R, Gori AM, Martini F, Brunelli T, Filippini M, Francalanci I et al. (1996). n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostaglandins Leukot Essent Fatty Acids 54: 439444.
  • Accini R, Rosina M, Barmonti F, Della Noce C, Tonini A, Bernacchi F et al. (2006). Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis 16: 121127.
  • Ahmed AA, Holub BJ (1984). Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil. Lipids 19: 617624.
  • Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC et al. (1998). Fish consumption and risk of sudden cardiac death. JAMA 279: 2328.
  • Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC et al. (2002). Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 11131118.
  • Angerer P, Kothny W, Stork S, von Schacky C (2002). Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 54: 183190.
  • Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S et al. (2005). Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201: 713722.
  • Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC (1995). Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 332: 977982.
  • Baartscheer A, Schumacher CA, Belterman CN, Coronel R, Fiolet JW (2003). SR calcium handling and calcium after-transients in a rabbit model of heart failure. Cardiovasc Res 58: 99108.
  • Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J (2006). Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis 184: 237246.
  • Bang HO, Dyerberg J (1980). The bleeding tendency in Greenland Eskimos. Dan Med Bull 27: 202205.
  • Bang HO, Dyerberg J, Nielsen AB (1971). Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1: 11431145.
  • Bang HO, Dyerberg J, Hjoorne N (1976). The composition of food consumed by Greenland Eskimos. Acta Med Scand 200: 6973.
  • Bays H (2006). Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol 98: 71i76i.
  • Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen H, Pedersen JI (2003). Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin Sci (Lond) 105: 1320.
  • Billman GE, Hallaq H, Leaf A (1994). Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 91: 44274430.
  • Billman GE, Kang JX, Leaf A (1997). Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 32: 11611168.
  • Billman GE, Kang JX, Leaf A (1999). Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99: 24522457.
  • Blok WL, Deslypere JP, Demacker PN, van der Ven–Jongekrÿg J, Hectors MP, van der Meer JW et al. (1997). Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur J Clin Invest 27: 10031008.
  • Breslow JL (1996). Mouse models of atherosclerosis. Science 272: 685688.
  • Brouwer IA, Geelen A, Katan MB (2006a). n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease. Prog Lipid Res 45: 357367.
  • Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC (2006b). Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 151: 857862.
  • Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF et al. (2006c). Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295: 26132619.
  • Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA (2007). The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9: 7080.
  • Brox JH, Killie JE, Osterud B, Holme S, Nordoy A (1983). Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med Scand 213: 137144.
  • Bucher HC, Hengstler P, Schindler C, Meier G (2002). N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112: 298304.
  • Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D et al. (2002). Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105: 18161823.
  • Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM et al. (1989). Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2: 757761.
  • Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T et al. (2003). Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57: 193200.
  • Burr ML, Dunstan FD, George CH (2005). Is fish oil good or bad for heart disease? Two trials with apparently conflicting results. J Membr Biol 206: 155163.
  • Calabresi L, Donati D, Pazzucconi F, Sirtori CR, Franceschini G (2000). Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. Atherosclerosis 148: 387396.
  • Calder PC (2001). N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters of another fishy tale? Nutr Res 21: 309341.
  • Calder PC (2006). n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S1519S.
  • Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, De Ruvo E et al. (2005). N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45: 17231728.
  • Cannon JG, Fiatarone MA, Meydani M, Gong J, Scott L, Blumberg JB et al. (1995). Aging and dietary modulation of elastase and interleukin-1 beta secretion. Am J Physiol 268: R208R213.
  • Capdevila J, Parkhill L, Chacos N, Okita R, Masters BS, Estabrook RW (1981). The oxidative metabolism of arachidonic acid by purified cytochromes P-450. Biochem Biophys Res Commun 101: 13571363.
  • Casos K, Saiz MP, Ruiz-Sanz JI, Mitjavila MT (2008). Atherosclerosis prevention by a fish oil-rich diet in apoE(-/-) mice is associated with a reduction of endothelial adhesion molecules. Atherosclerosis 201: 306317.
  • Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ (1996). The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63: 116122.
  • Chan DC, Watts GF, Barrett PH, Beilin LJ, Redgrave TG, Mori TA (2002). Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. Diabetes 51: 23772386.
  • Christensen JH, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K et al. (1997). Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 79: 16701673.
  • Codde JP, Vandongen R, Mori TA, Beilin LJ, Hill KJ (1987). Can the synthesis of platelet-activating factor, a potent vasodilator and pro-aggregatory agent, be altered by dietary marine oils? Clin Exp Pharmacol Physiol 14: 197202.
  • Collins T, Cybulsky MI (2001). NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107: 255264.
  • Cooper AL, Gibbons L, Horan MA, Little RA, Rothwell NJ (1993). Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin Nutr 12: 321328.
  • Coronel R, Wilms-Schopman FJ, den Ruijter HM, Belterman CN, Schumacher CA, Opthof T et al. (2007). Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res 73: 386394.
  • Croset M, Lagarde M (1986). In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets – effect on aggregation. Thromb Haemost 56: 5762.
  • Cybulsky MI, Gimbrone MA Jr. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788791.
  • Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 13871397.
  • Davidson MH (2006). Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98: 27i33i.
  • Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA et al. (2007). Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 29: 13541367.
  • Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P et al. (1997). Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336: 10461053.
  • De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby, P (1994). The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14: 18291836.
  • De Caterina R, Bernini W, Carluccio MA, Liao JK, Libby P (1998). Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 39: 10621070.
  • De Caterina R, Liao JK, Libby P (2000). Fatty acid modulation of endothelial activation. Am J Clin Nutr 71: 213S223S.
  • Deckelbaum RJ, Leaf A, Mozaffarian D, Jacobson TA, Harris WS, Akabas SR (2008). Conclusions and recommendations from the symposium, Beyond Cholesterol: prevention and treatment of coronary heart disease with n-3 fatty acids. Am J Clin Nutr 87: 2010S2012S.
  • Dolecek TA, Granditis G (1991). Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 66: 205216.
  • Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A et al. (2008). Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112: 848855.
  • Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD (1998). The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102: 145152.
  • Durrington PN, Bhatnagar D, Mackness MI, Morgan J, Julier K, Khan MA et al. (2001). An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 85: 544548.
  • Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR (1978). Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2: 117119.
  • Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW et al. (1989). The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320: 265271.
  • Frost L, Vestergaard P (2005). n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81: 5054.
  • Fujioka S, Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S et al. (2006). The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects – a randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol (Tokyo) 52: 261265.
  • Geelen A, Brouwer IA, Zock PL, Katan MB (2004). Antiarrhythmic effects of n-3 fatty acids: evidence from human studies. Curr Opin Lipidol 15: 2530.
  • Geelen A, Brouwer IA, Schouten EG, Maan AC, Katan MB, Zock PL (2005). Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81: 416420.
  • Geleijnse JM, Brouwer IA, Feskens EJ (2006). Risks and benefits of omega 3 fats: health benefits of omega 3 fats are in doubt. BMJ 332: 915916.
  • GISSI Investigators (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447455.
  • Gissi-Hf I (2008). Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372: 12231230.
  • Goodnight SH (1986). The antithrombotic effects of fish oil. In: Simopoulos AP, Kifer RR, Martin RT (eds) Health Effects of Polyunsaturated Falty Acids in Seafood, pp. 135149. Academic Press: Orlando.
  • Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP (2005). Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J Lipid Res 46: 14741483.
  • Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP (2006). Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84: 4453.
  • Grundt H, Nilsen DW, Mansoor MA, Hetland O, Nordoy A (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33: 8895.
  • Harris WS (1997). n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65: 1645S1654S.
  • Harris WS, Bulchandani D (2006). Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17: 387393.
  • Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M et al. (1997). Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 4: 385391.
  • He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR et al. (2004). Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109: 27052711.
  • Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Kamugai A et al. (1980). Eicosapentaenoic acid and platelet function in Japanese. Lancet 2: 11321133.
  • Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L et al. (2005). Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr 81: 583589.
  • Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN (2003). Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278: 1467714687.
  • Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al. (2006). Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332: 752760.
  • Hornstra G (2001). Influence of dietary fat type on arterial thrombosis tendency. J Nutr Health Aging 5: 160166.
  • Hu FB, Willett WC (2002). Optimal diets for prevention of coronary heart disease. JAMA 288: 25692578.
  • Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM et al. (2002). Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287: 18151821.
  • Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A et al. (2006). Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103: 1127611281.
  • Huikuri HV, Castellanos A, Myerburg RJ (2001). Sudden death due to cardiac arrhythmias. N Engl J Med 345: 14731482.
  • Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD (2002). Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39: 690694.
  • Jellema A, Plat J, Mensink RP (2004). Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34: 766773.
  • Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P (2001). Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 50: 373378.
  • Jump DB (2008). N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19: 242247.
  • Jump DB, Clarke SD (1999). Regulation of gene expression by dietary fat. Annu Rev Nutr 19: 6390.
  • Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S et al. (2007). Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86: 16701679.
  • Kelley DS, Taylor PC, Nelson GJ, Schmidt PC, Ferretti A, Erickson KL et al. (1999). Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34: 317324.
  • Kew S, Banerjee T, Minihane AM, Finnegan YE, Muggli R, Albers R et al. (2003). Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 77: 12871295.
  • Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P (2004). Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 79: 674681.
  • Khalfoun B, Thibault G, Bardos P, Lebranchu Y (1996). Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation 62: 16491657.
  • Kramer HJ, Stevens J, Grimminger F, Seeger W (1996). Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochem Pharmacol 52: 12111217.
  • Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG et al. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11: 779791.
  • Kristensen SD, Schmidt EB, Andersen HR, Dyerberg J (1987). Fish oil in angina pectoris. Atherosclerosis 64: 1319.
  • Kristensen SD, Schmidt EB, Dyerberg J (1989). Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med Suppl 731: 141150.
  • Kromhout D, Bosschieter EB, de Lezenne CC (1985). The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 12051209.
  • Lauterbach B, Barbosa-Sicard E, Wang MH, Honeck H, Kargel E, Theuer J et al. (2002). Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 39: 609613.
  • Leaf A, Kang JX (1996). Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence. J Intern Med 240: 512.
  • Leaf A, Kang JX, Xiao YF, Billman GE (1999). n-3 fatty acids in the prevention of cardiac arrhythmias. Lipids 34 (Suppl.): S187S189.
  • Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX et al. (2005). Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112: 27622768.
  • Lee KW, Blann AD, Lip GY (2006). Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thromb Res 118: 305312.
  • Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF (1984). Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74: 19221933.
  • Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J III, Spur BW et al. (1985). Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312: 12171224.
  • Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS (2003). n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 77: 319325.
  • Libby P (2002). Inflammation in atherosclerosis. Nature 420: 868874.
  • Liu Y, Zhang Y, Schmelzer K, Lee TS, Fang X, Zhu Y et al. (2005). The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci USA 102: 1674716752.
  • Lowe GD (2005). Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3: 16181627.
  • Lu G, Windsor SL, Harris WS (1999). Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem 10: 151158.
  • Lu T, VanRollins M, Lee HC (2002). Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study. Mol Pharmacol 62: 10761083.
  • McKenney JM, Swearingen D, Di Spirito M, Doyle R, Pantaleon C, Kling D et al. (2006). Study of the pharmacokinetic interaction between simvastatin and prescription omega-3-acid ethyl esters. J Clin Pharmacol 46: 785791.
  • McLennan PL (1993). Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 57: 207212.
  • McLennan PL, Abeywardena MY, Charnock JS (1988). Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 116: 709717.
  • McLennan PL, Bridle TM, Abeywardena MY, Charnock JS (1993). Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 58: 666669.
  • Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A et al. (2003). Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278: 4380743817.
  • Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T et al. (2006). The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 103: 1518415189.
  • Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y et al. (2008). Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 197: 524533.
  • Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A et al. (1991). Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121: 547555.
  • Miles EA, Banerjee T, Dooper MM, M'Rabet L, Graus YM, Calder PC (2004). The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br J Nutr 91: 893903.
  • Miller M, Zhan M, Havas S (2005). High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med 165: 20632068.
  • Molvig J, Pociot F, Worsaae H, Wogensen LD, Baek L, Christensen P et al. (1991). Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol 34: 399410.
  • Mori TA, Woodman RJ (2006). The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9: 95104.
  • Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J (1997). Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 17: 279286.
  • Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ (2003). Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35: 772781.
  • Mozaffarian D (2007). JELIS, fish oil, and cardiac events. Lancet 369: 10621063.
  • Mozaffarian D (2008). Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 87: 1991S1996S.
  • Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS (2003). Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107: 13721377.
  • Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF et al. (2004). Fish intake and risk of incident atrial fibrillation. Circulation 110: 368373.
  • Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB (2005). Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112: 19451952.
  • Mozaffarian D, Gottdiener JS, Siscovick DS (2006). Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 97: 216222.
  • Nakamura MT, Cheon Y, Li Y, Nara TY (2004). Mechanisms of regulation of gene expression by fatty acids. Lipids 39: 10771083.
  • Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H (1979). Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 76: 944948.
  • Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K et al. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 12761279.
  • Osler M, Andreasen AH, Hoidrup S (2003). No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged, Danish adults. J Clin Epidemiol 56: 274279.
  • Pairet M, Engelhardt G (1996). Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 10: 117.
  • Park Y, Jones PG, Harris WS (2004). Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr 80: 4550.
  • Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D et al. (1997). Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145: 876887.
  • Pownall HJ, Brauchi D, Kilinc C, Osmundsen K, Pao Q, Payton-Ross C et al. (1999). Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis 143: 285297.
  • Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS et al. (2005). Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293: 28842891.
  • Rodriguez BL, Sharp DS, Abbott RD, Burchfiel CM, Masaki K, Chyou PH et al. (1996). Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation 94: 952956.
  • Ross R (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801809.
  • Ross R (1999). Atherosclerosis – an inflammatory disease. N Engl J Med 340: 115126.
  • de Roos B, Duivenvoorden I, Rucklidge G, Reid M, Ross K, Lamers RJ et al. (2005a). Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data. FASEB J 19: 813815.
  • de Roos B, Mercer DK, Wainwright C, Thies F (2005b). Effect of long chain n-3 PUFA on endothelial activation, endothelial function and atheromatous plaque stability. Current Nutrition and Food. Science 1: 167177.
  • de Roos B, Duthie SJ, Polley AC, Mulholland F, Bouwman FG, Heim C et al. (2008a). Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J Proteome Res 7: 22802290.
  • de Roos B, Geelen A, Ross K, Rucklidge G, Reid M, Duncan G et al. (2008b). Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics 8: 19651974.
  • den Ruijter HM, Berecki G, Opthof T, Verkerk AO, Zock PL, Coronel R (2007). Pro- and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc Res 73: 316325.
  • den Ruijter HM, Berecki G, Verkerk AO, Bakker D, Baartscheer A, Schumacher CA et al. (2008). Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 117: 536544.
  • Salonen JT, Nyyssonen K, Salonen R (1995). Fish intake and the risk of coronary disease. N Engl J Med 333: 937.
  • Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH (2007). Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr 137: 17761782.
  • von Schacky C (2008). Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? Curr Opin Clin Nutr Metab Care 11: 9499.
  • von Schacky C, Kiefl R, Jendraschak E, Kaminski WE (1993). n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo. J Lab Clin Med 121: 302309.
  • von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H (1999). The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130: 554562.
  • Schiano V, Laurenzano E, Brevetti G, De Maio JI, Lanero S, Scopacasa F et al. (2008). Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr 27: 241247.
  • Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, Hammock BD (2005). Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102: 97729777.
  • Schmelzer KR, Inceoglu B, Kubala L, Kim IH, Jinks SL, Eiserich JP et al. (2006). Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103: 1364613651.
  • Schmidt EB, Varming K, Moller JM, Bulow PI, Madsen P, Dyerberg J (1996). No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Lab Invest 56: 8792.
  • Scirica BM, Morrow DA (2006). Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 113: 21282134.
  • Seierstad SL, Seljeflot I, Johansen O, Hansen R, Haugen M, Rosenlund G et al. (2005). Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. Eur J Clin Invest 35: 5259.
  • Serhan CN, Chiang N (2008). Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153 (Suppl. 1): S200S215.
  • Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192: 11971204.
  • Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G et al. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 10251037.
  • Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T et al. (2006). Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 176: 18481859.
  • Serhan CN, Chiang N, Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349361.
  • Siess W, Roth P, Scherer B, Kurzmann I, Bohlig B, Weber PC (1980). Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1: 441444.
  • Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J et al. (1995). Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274: 13631367.
  • Siscovick DS, Raghunathan T, King I, Weinmann S, Bovbjerg VE, Kushi L et al. (2000). Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 71: 208S212S.
  • Smith WL (2005). Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 17: 174182.
  • Spector AA, Norris AW (2007). Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292: C996C1012.
  • Spector AA, Fang X, Snyder GD, Weintraub NL (2004). Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43: 5590.
  • Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR (1993). Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91: 651660.
  • Stalenhoef AF, de Graaf J, Wittekoek ME, Bredie SJ, Demacker PN, Kastelein JJ (2000). The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis 153: 129138.
  • Sublette ME, Bosetti F, DeMar JC, Ma K, Bell JM, Fagin-Jones S et al. (2007). Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord 9: 759765.
  • Swann PG, Venton DL, Le Breton GC (1989). Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett 243: 244246.
  • Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA et al. (2001). Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36: 11831193.
  • Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP et al. (2003). Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361: 477485.
  • Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio KB, Hong S et al. (2006). Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol 13: 11931202.
  • Trebble T, Arden NK, Stroud MA, Wootton SA, Burdge GC, Miles EA et al. (2003). Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr 90: 405412.
  • Vanschoonbeek K, Feijge MA, Paquay M, Rosing J, Saris W, Kluft C et al. (2004). Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 24: 17341740.
  • Vega-Lopez S, Kaul N, Devaraj S, Cai RY, German B, Jialal I (2004). Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 53: 236240.
  • Verkerk AO, van Ginneken AC, Berecki G, den Ruijter HM, Schumacher CA, Veldkamp MW et al. (2006). Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 70: 509520.
  • Wallace FA, Miles EA, Calder PC (2003). Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr 89: 679689.
  • Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B et al. (2006). n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84: 517.
  • Wang HH, Hung TM, Wei J, Chiang AN (2004). Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res 61: 169176.
  • Weber C, Erl W, Pietsch A, Danesch U, Weber PC (1995). Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15: 622628.
  • Weber PC (1989). Clinical studies on the effects of n-3 fatty acids on cells and eicosanoids in the cardiovascular system. J Intern Med Suppl 225: 6168.
  • Whelton SP, He J, Whelton PK, Muntner P (2004). Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 93: 11191123.
  • Xu Z, Riediger N, Innis S, Moghadasian MH (2007). Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice. Eur J Nutr 46: 103110.
  • Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC (2000). Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 30: 260274.
  • Ye D, Zhang D, Oltman C, Dellsperger K, Lee HC, VanRollins M (2002). Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther 303: 768776.
  • Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 10901098.
  • Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW et al. (2000). Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87: 992998.
  • Yuan JM, Ross RK, Gao YT, Yu MC (2001). Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol 154: 809816.
  • Yusof HM, Miles EA, Calder PC (2008). Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men. Prostaglandins Leukot Essent Fatty Acids 78: 219228.
  • Zampolli A, Bysted A, Leth T, Mortensen A, De Caterina R, Falk E (2006). Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis 184: 7885.
  • Zhao X, Yamamoto T, Newman JW, Kim IH, Watanabe T, Hammock BD et al. (2004). Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J Am Soc Nephrol 15: 12441253.